MXPA00012905A - Formulations for controlling human lice - Google Patents
Formulations for controlling human liceInfo
- Publication number
- MXPA00012905A MXPA00012905A MXPA/A/2000/012905A MXPA00012905A MXPA00012905A MX PA00012905 A MXPA00012905 A MX PA00012905A MX PA00012905 A MXPA00012905 A MX PA00012905A MX PA00012905 A MXPA00012905 A MX PA00012905A
- Authority
- MX
- Mexico
- Prior art keywords
- formulation
- hair
- lice
- formulations
- spinosyn
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 162
- 238000009472 formulation Methods 0.000 title claims abstract description 110
- 241000517307 Pediculus humanus Species 0.000 title claims description 17
- 229930185156 spinosyn Natural products 0.000 claims abstract description 42
- 150000003839 salts Chemical class 0.000 claims abstract description 25
- 238000000034 method Methods 0.000 claims abstract description 18
- 208000028454 lice infestation Diseases 0.000 claims abstract description 10
- 241001674048 Phthiraptera Species 0.000 claims description 36
- 239000002453 shampoo Substances 0.000 claims description 36
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 30
- 239000004094 surface-active agent Substances 0.000 claims description 21
- 229920001296 polysiloxane Polymers 0.000 claims description 19
- 239000000463 material Substances 0.000 claims description 18
- 206010061217 Infestation Diseases 0.000 claims description 13
- 235000013601 eggs Nutrition 0.000 claims description 12
- 239000000375 suspending agent Substances 0.000 claims description 9
- 150000001408 amides Chemical class 0.000 claims description 8
- 210000004761 scalp Anatomy 0.000 claims description 6
- 241000517306 Pediculus humanus corporis Species 0.000 claims description 5
- 241000517304 Pthirus pubis Species 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 239000003814 drug Substances 0.000 claims description 2
- 238000011200 topical administration Methods 0.000 claims description 2
- 239000004480 active ingredient Substances 0.000 claims 1
- 230000003038 pediculicidal effect Effects 0.000 abstract description 3
- -1 salts Salts Chemical class 0.000 description 62
- 125000004432 carbon atom Chemical group C* 0.000 description 38
- 235000002639 sodium chloride Nutrition 0.000 description 29
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 21
- 239000006210 lotion Substances 0.000 description 19
- 239000000047 product Substances 0.000 description 19
- 125000000217 alkyl group Chemical group 0.000 description 18
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 18
- 150000001875 compounds Chemical class 0.000 description 18
- 230000003750 conditioning effect Effects 0.000 description 17
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 17
- 239000003795 chemical substances by application Substances 0.000 description 16
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 15
- 229960003237 betaine Drugs 0.000 description 14
- 235000014113 dietary fatty acids Nutrition 0.000 description 14
- 239000000194 fatty acid Substances 0.000 description 14
- 229930195729 fatty acid Natural products 0.000 description 14
- 150000004665 fatty acids Chemical class 0.000 description 14
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 14
- JFLRKDZMHNBDQS-UCQUSYKYSA-N CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C(=C[C@H]3[C@@H]2CC(=O)O1)C)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C.CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C=C[C@H]3C2CC(=O)O1)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C Chemical compound CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C(=C[C@H]3[C@@H]2CC(=O)O1)C)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C.CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C=C[C@H]3C2CC(=O)O1)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C JFLRKDZMHNBDQS-UCQUSYKYSA-N 0.000 description 10
- 239000005930 Spinosad Substances 0.000 description 10
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 10
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 10
- 229910052708 sodium Inorganic materials 0.000 description 10
- 239000011734 sodium Substances 0.000 description 10
- 235000015424 sodium Nutrition 0.000 description 10
- 229940014213 spinosad Drugs 0.000 description 10
- SRJQTHAZUNRMPR-UHFFFAOYSA-N spinosyn A Natural products CC1C(=O)C2=CC3C4CC(OC5C(C(OC)C(OC)C(C)O5)OC)CC4C=CC3C2CC(=O)OC(CC)CCCC1OC1CCC(N(C)C)C(C)O1 SRJQTHAZUNRMPR-UHFFFAOYSA-N 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 229910019142 PO4 Inorganic materials 0.000 description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 230000002209 hydrophobic effect Effects 0.000 description 9
- 239000010452 phosphate Substances 0.000 description 9
- 239000003760 tallow Substances 0.000 description 9
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 8
- 239000002253 acid Substances 0.000 description 8
- 150000001298 alcohols Chemical class 0.000 description 8
- 150000002191 fatty alcohols Chemical class 0.000 description 8
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 239000002562 thickening agent Substances 0.000 description 8
- 150000001412 amines Chemical class 0.000 description 7
- 229960000541 cetyl alcohol Drugs 0.000 description 7
- WSDISUOETYTPRL-UHFFFAOYSA-N dmdm hydantoin Chemical compound CC1(C)N(CO)C(=O)N(CO)C1=O WSDISUOETYTPRL-UHFFFAOYSA-N 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 239000003995 emulsifying agent Substances 0.000 description 7
- 239000002736 nonionic surfactant Substances 0.000 description 7
- SRJQTHAZUNRMPR-UYQKXTDMSA-N spinosyn A Chemical compound O([C@H]1CCC[C@@H](OC(=O)C[C@H]2[C@@H]3C=C[C@@H]4C[C@H](C[C@H]4[C@@H]3C=C2C(=O)[C@@H]1C)O[C@H]1[C@@H]([C@H](OC)[C@@H](OC)[C@H](C)O1)OC)CC)[C@H]1CC[C@H](N(C)C)[C@@H](C)O1 SRJQTHAZUNRMPR-UYQKXTDMSA-N 0.000 description 7
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 6
- 241000282412 Homo Species 0.000 description 6
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 125000001931 aliphatic group Chemical group 0.000 description 6
- 239000003093 cationic surfactant Substances 0.000 description 6
- 238000009833 condensation Methods 0.000 description 6
- 230000005494 condensation Effects 0.000 description 6
- ZCPCLAPUXMZUCD-UHFFFAOYSA-M dihexadecyl(dimethyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCC ZCPCLAPUXMZUCD-UHFFFAOYSA-M 0.000 description 6
- 239000004205 dimethyl polysiloxane Substances 0.000 description 6
- 239000012530 fluid Substances 0.000 description 6
- 150000002632 lipids Chemical class 0.000 description 6
- 229910052757 nitrogen Inorganic materials 0.000 description 6
- 150000003254 radicals Chemical class 0.000 description 6
- 238000011282 treatment Methods 0.000 description 6
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 5
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Ethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 description 5
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 239000002537 cosmetic Substances 0.000 description 5
- 229940008099 dimethicone Drugs 0.000 description 5
- 238000000855 fermentation Methods 0.000 description 5
- 230000004151 fermentation Effects 0.000 description 5
- JLYXXMFPNIAWKQ-UHFFFAOYSA-N gamma-hexachlorocyclohexane Natural products ClC1C(Cl)C(Cl)C(Cl)C(Cl)C1Cl JLYXXMFPNIAWKQ-UHFFFAOYSA-N 0.000 description 5
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 5
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 5
- 229920002379 silicone rubber Polymers 0.000 description 5
- 239000004945 silicone rubber Substances 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical group CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 4
- 241000238631 Hexapoda Species 0.000 description 4
- 229910002651 NO3 Inorganic materials 0.000 description 4
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 125000003342 alkenyl group Chemical group 0.000 description 4
- 125000000129 anionic group Chemical group 0.000 description 4
- 239000003945 anionic surfactant Substances 0.000 description 4
- 230000001276 controlling effect Effects 0.000 description 4
- 150000002194 fatty esters Chemical class 0.000 description 4
- JLYXXMFPNIAWKQ-GNIYUCBRSA-N gamma-hexachlorocyclohexane Chemical compound Cl[C@H]1[C@H](Cl)[C@@H](Cl)[C@@H](Cl)[C@H](Cl)[C@H]1Cl JLYXXMFPNIAWKQ-GNIYUCBRSA-N 0.000 description 4
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 4
- 229960002809 lindane Drugs 0.000 description 4
- 229910052698 phosphorus Inorganic materials 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 239000001488 sodium phosphate Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 239000003981 vehicle Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 3
- 244000060011 Cocos nucifera Species 0.000 description 3
- 235000013162 Cocos nucifera Nutrition 0.000 description 3
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- QZXSMBBFBXPQHI-UHFFFAOYSA-N N-(dodecanoyl)ethanolamine Chemical compound CCCCCCCCCCCC(=O)NCCO QZXSMBBFBXPQHI-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 244000300264 Spinacia oleracea Species 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- VXSIXFKKSNGRRO-MXOVTSAMSA-N [(1s)-2-methyl-4-oxo-3-[(2z)-penta-2,4-dienyl]cyclopent-2-en-1-yl] (1r,3r)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropane-1-carboxylate;[(1s)-2-methyl-4-oxo-3-[(2z)-penta-2,4-dienyl]cyclopent-2-en-1-yl] (1r,3r)-3-[(e)-3-methoxy-2-methyl-3-oxoprop-1-enyl Chemical class CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)O[C@@H]1C(C)=C(C\C=C/C=C)C(=O)C1.CC1(C)[C@H](/C=C(\C)C(=O)OC)[C@H]1C(=O)O[C@@H]1C(C)=C(C\C=C/C=C)C(=O)C1 VXSIXFKKSNGRRO-MXOVTSAMSA-N 0.000 description 3
- 150000008051 alkyl sulfates Chemical class 0.000 description 3
- 125000002947 alkylene group Chemical group 0.000 description 3
- 235000019270 ammonium chloride Nutrition 0.000 description 3
- BTBJBAZGXNKLQC-UHFFFAOYSA-N ammonium lauryl sulfate Chemical compound [NH4+].CCCCCCCCCCCCOS([O-])(=O)=O BTBJBAZGXNKLQC-UHFFFAOYSA-N 0.000 description 3
- 229940063953 ammonium lauryl sulfate Drugs 0.000 description 3
- 229940047662 ammonium xylenesulfonate Drugs 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- VEMKTZHHVJILDY-UXHICEINSA-N bioresmethrin Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OCC1=COC(CC=2C=CC=CC=2)=C1 VEMKTZHHVJILDY-UXHICEINSA-N 0.000 description 3
- 229940082500 cetostearyl alcohol Drugs 0.000 description 3
- 239000007795 chemical reaction product Substances 0.000 description 3
- 229940096386 coconut alcohol Drugs 0.000 description 3
- 239000000084 colloidal system Substances 0.000 description 3
- 239000007859 condensation product Substances 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- 239000003599 detergent Substances 0.000 description 3
- 239000000975 dye Substances 0.000 description 3
- 239000013020 final formulation Substances 0.000 description 3
- 229910052736 halogen Inorganic materials 0.000 description 3
- 150000002367 halogens Chemical class 0.000 description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000002917 insecticide Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- HESSGHHCXGBPAJ-UHFFFAOYSA-N n-[3,5,6-trihydroxy-1-oxo-4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexan-2-yl]acetamide Chemical compound CC(=O)NC(C=O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O HESSGHHCXGBPAJ-UHFFFAOYSA-N 0.000 description 3
- BOUCRWJEKAGKKG-UHFFFAOYSA-N n-[3-(diethylaminomethyl)-4-hydroxyphenyl]acetamide Chemical compound CCN(CC)CC1=CC(NC(C)=O)=CC=C1O BOUCRWJEKAGKKG-UHFFFAOYSA-N 0.000 description 3
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- HYJYGLGUBUDSLJ-UHFFFAOYSA-N pyrethrin Natural products CCC(=O)OC1CC(=C)C2CC3OC3(C)C2C2OC(=O)C(=C)C12 HYJYGLGUBUDSLJ-UHFFFAOYSA-N 0.000 description 3
- 229940070846 pyrethrins Drugs 0.000 description 3
- 239000002728 pyrethroid Substances 0.000 description 3
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 241000894007 species Species 0.000 description 3
- RDECBWLKMPEKPM-PSCJHHPTSA-N spinosyn D Chemical compound O([C@H]1CCC[C@@H](OC(=O)C[C@H]2[C@@H]3C=C(C)[C@@H]4C[C@H](C[C@H]4[C@@H]3C=C2C(=O)[C@@H]1C)O[C@H]1[C@@H]([C@H](OC)[C@@H](OC)[C@H](C)O1)OC)CC)[C@H]1CC[C@H](N(C)C)[C@@H](C)O1 RDECBWLKMPEKPM-PSCJHHPTSA-N 0.000 description 3
- RDECBWLKMPEKPM-UHFFFAOYSA-N spinosyn D Natural products CC1C(=O)C2=CC3C4CC(OC5C(C(OC)C(OC)C(C)O5)OC)CC4C(C)=CC3C2CC(=O)OC(CC)CCCC1OC1CCC(N(C)C)C(C)O1 RDECBWLKMPEKPM-UHFFFAOYSA-N 0.000 description 3
- SFVFIFLLYFPGHH-UHFFFAOYSA-M stearalkonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 SFVFIFLLYFPGHH-UHFFFAOYSA-M 0.000 description 3
- 239000012747 synergistic agent Substances 0.000 description 3
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 3
- FAGMGMRSURYROS-UHFFFAOYSA-M trihexadecyl(methyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(CCCCCCCCCCCCCCCC)CCCCCCCCCCCCCCCC FAGMGMRSURYROS-UHFFFAOYSA-M 0.000 description 3
- 239000002888 zwitterionic surfactant Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 description 2
- ICIDSZQHPUZUHC-UHFFFAOYSA-N 2-octadecoxyethanol Chemical compound CCCCCCCCCCCCCCCCCCOCCO ICIDSZQHPUZUHC-UHFFFAOYSA-N 0.000 description 2
- 241001427556 Anoplura Species 0.000 description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 2
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 241000255925 Diptera Species 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical class OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- CEAGUSGLAUVBEQ-UHFFFAOYSA-N Forosamine Natural products CC1CC(N(C)C)CC(O)O1 CEAGUSGLAUVBEQ-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- OTGQIQQTPXJQRG-UHFFFAOYSA-N N-(octadecanoyl)ethanolamine Chemical compound CCCCCCCCCCCCCCCCCC(=O)NCCO OTGQIQQTPXJQRG-UHFFFAOYSA-N 0.000 description 2
- 241000517324 Pediculidae Species 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 241000517305 Pthiridae Species 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 239000012876 carrier material Substances 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 229940073669 ceteareth 20 Drugs 0.000 description 2
- 229940081733 cetearyl alcohol Drugs 0.000 description 2
- 229940074979 cetyl palmitate Drugs 0.000 description 2
- WOWHHFRSBJGXCM-UHFFFAOYSA-M cetyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)C WOWHHFRSBJGXCM-UHFFFAOYSA-M 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- 229940086555 cyclomethicone Drugs 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 231100000517 death Toxicity 0.000 description 2
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 2
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 2
- 229910000397 disodium phosphate Inorganic materials 0.000 description 2
- 235000019800 disodium phosphate Nutrition 0.000 description 2
- ILRSCQWREDREME-UHFFFAOYSA-N dodecanamide Chemical compound CCCCCCCCCCCC(N)=O ILRSCQWREDREME-UHFFFAOYSA-N 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- SZGAAHDUAFVZSS-SFYZADRCSA-N forosamine Chemical compound C[C@@H](O)[C@@H](N(C)C)CCC=O SZGAAHDUAFVZSS-SFYZADRCSA-N 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 2
- 229940051250 hexylene glycol Drugs 0.000 description 2
- 239000003752 hydrotrope Substances 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 2
- XCOBTUNSZUJCDH-UHFFFAOYSA-B lithium magnesium sodium silicate Chemical class [Li+].[Li+].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 XCOBTUNSZUJCDH-UHFFFAOYSA-B 0.000 description 2
- 150000004668 long chain fatty acids Chemical class 0.000 description 2
- 239000003120 macrolide antibiotic agent Substances 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 2
- 235000019799 monosodium phosphate Nutrition 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
- MPQXHAGKBWFSNV-UHFFFAOYSA-N oxidophosphanium Chemical group [PH3]=O MPQXHAGKBWFSNV-UHFFFAOYSA-N 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- SSZBUIDZHHWXNJ-UHFFFAOYSA-N palmityl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCCCC SSZBUIDZHHWXNJ-UHFFFAOYSA-N 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 159000000001 potassium salts Chemical class 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 125000001453 quaternary ammonium group Chemical group 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000000518 rheometry Methods 0.000 description 2
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 2
- 229940100459 steareth-20 Drugs 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- DIORMHZUUKOISG-UHFFFAOYSA-N sulfoformic acid Chemical compound OC(=O)S(O)(=O)=O DIORMHZUUKOISG-UHFFFAOYSA-N 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 150000003512 tertiary amines Chemical class 0.000 description 2
- 229910052721 tungsten Inorganic materials 0.000 description 2
- 229910052720 vanadium Inorganic materials 0.000 description 2
- 239000004034 viscosity adjusting agent Substances 0.000 description 2
- 229910052727 yttrium Inorganic materials 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- NHOWREQLQRFDRW-UHFFFAOYSA-N (methoxyamino)oxymethane Chemical compound CONOC NHOWREQLQRFDRW-UHFFFAOYSA-N 0.000 description 1
- ZPFAVCIQZKRBGF-UHFFFAOYSA-N 1,3,2-dioxathiolane 2,2-dioxide Chemical compound O=S1(=O)OCCO1 ZPFAVCIQZKRBGF-UHFFFAOYSA-N 0.000 description 1
- NYEOFIBTYDEESJ-UHFFFAOYSA-N 1-[2-[2-(2-dimethylphosphorylethoxy)ethoxy]ethoxy]nonane Chemical compound CCCCCCCCCOCCOCCOCCP(C)(C)=O NYEOFIBTYDEESJ-UHFFFAOYSA-N 0.000 description 1
- XDTVGYSKNJTGBM-UHFFFAOYSA-N 1-[2-hydroxy-4-[2-(2-nonoxyethoxy)ethoxy]butyl]sulfinyl-4-[2-(2-nonoxyethoxy)ethoxy]butan-2-ol Chemical compound C(COCCOCCOCCCCCCCCC)C(CS(=O)CC(CCOCCOCCOCCCCCCCCC)O)O XDTVGYSKNJTGBM-UHFFFAOYSA-N 0.000 description 1
- FOSDJCYTRLJWKQ-UHFFFAOYSA-N 1-[bis(2-hydroxyethyl)phosphanyl]-3-dodecoxypropan-2-ol Chemical compound CCCCCCCCCCCCOCC(O)CP(CCO)CCO FOSDJCYTRLJWKQ-UHFFFAOYSA-N 0.000 description 1
- MNLXVEGUYZHTJQ-UHFFFAOYSA-N 1-[ethyl(methyl)phosphoryl]tetradecane Chemical compound CCCCCCCCCCCCCCP(C)(=O)CC MNLXVEGUYZHTJQ-UHFFFAOYSA-N 0.000 description 1
- JTZHVECVJFPRQY-UHFFFAOYSA-N 1-[methyl(tetradecyl)phosphoryl]propan-2-ol Chemical compound CCCCCCCCCCCCCCP(C)(=O)CC(C)O JTZHVECVJFPRQY-UHFFFAOYSA-N 0.000 description 1
- CXRUQTPIHDKFTG-UHFFFAOYSA-N 1-diethylphosphoryldodecane Chemical compound CCCCCCCCCCCCP(=O)(CC)CC CXRUQTPIHDKFTG-UHFFFAOYSA-N 0.000 description 1
- BQLLFEURQGITEW-UHFFFAOYSA-N 1-diethylphosphoryltetradecane Chemical compound CCCCCCCCCCCCCCP(=O)(CC)CC BQLLFEURQGITEW-UHFFFAOYSA-N 0.000 description 1
- SIDULKZCBGMXJL-UHFFFAOYSA-N 1-dimethylphosphoryldodecane Chemical compound CCCCCCCCCCCCP(C)(C)=O SIDULKZCBGMXJL-UHFFFAOYSA-N 0.000 description 1
- ATIFDPMZFAVQLR-UHFFFAOYSA-N 1-dimethylphosphorylhexadecane Chemical compound CCCCCCCCCCCCCCCCP(C)(C)=O ATIFDPMZFAVQLR-UHFFFAOYSA-N 0.000 description 1
- ZFZIAYPKDVEXDG-UHFFFAOYSA-N 1-dimethylphosphoryloctadecane Chemical compound CCCCCCCCCCCCCCCCCCP(C)(C)=O ZFZIAYPKDVEXDG-UHFFFAOYSA-N 0.000 description 1
- ZSGCBBCGHYYEGU-UHFFFAOYSA-N 1-dimethylphosphoryltetradecane Chemical compound CCCCCCCCCCCCCCP(C)(C)=O ZSGCBBCGHYYEGU-UHFFFAOYSA-N 0.000 description 1
- MRXVVGMYMYOILB-UHFFFAOYSA-N 1-dipropylphosphoryldodecane Chemical compound CCCCCCCCCCCCP(=O)(CCC)CCC MRXVVGMYMYOILB-UHFFFAOYSA-N 0.000 description 1
- WACFDLMMBCEBBS-UHFFFAOYSA-N 1-dodecoxy-5-(5-dodecoxy-4-hydroxypentyl)sulfinylpentan-2-ol Chemical compound CCCCCCCCCCCCOCC(O)CCCS(=O)CCCC(O)COCCCCCCCCCCCC WACFDLMMBCEBBS-UHFFFAOYSA-N 0.000 description 1
- CJPDBKNETSCHCH-UHFFFAOYSA-N 1-methylsulfinyldodecane Chemical compound CCCCCCCCCCCCS(C)=O CJPDBKNETSCHCH-UHFFFAOYSA-N 0.000 description 1
- QYRXERZWYVOCEQ-UHFFFAOYSA-N 1-methylsulfinyloctadecane Chemical compound CCCCCCCCCCCCCCCCCCS(C)=O QYRXERZWYVOCEQ-UHFFFAOYSA-N 0.000 description 1
- KRUABTDBQQLWLS-UHFFFAOYSA-N 1-methylsulfinyltetradecane Chemical compound CCCCCCCCCCCCCCS(C)=O KRUABTDBQQLWLS-UHFFFAOYSA-N 0.000 description 1
- HYTOZULGKGUFII-UHFFFAOYSA-N 1-methylsulfinyltridecan-3-ol Chemical compound CCCCCCCCCCC(O)CCS(C)=O HYTOZULGKGUFII-UHFFFAOYSA-N 0.000 description 1
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 description 1
- DJHVICOPLAQAGI-UHFFFAOYSA-N 18-methylnonadecan-1-amine Chemical compound CC(C)CCCCCCCCCCCCCCCCCN DJHVICOPLAQAGI-UHFFFAOYSA-N 0.000 description 1
- XFOQWQKDSMIPHT-UHFFFAOYSA-N 2,3-dichloro-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)C(Cl)=N1 XFOQWQKDSMIPHT-UHFFFAOYSA-N 0.000 description 1
- KMZHZAAOEWVPSE-UHFFFAOYSA-N 2,3-dihydroxypropyl acetate Chemical compound CC(=O)OCC(O)CO KMZHZAAOEWVPSE-UHFFFAOYSA-N 0.000 description 1
- NLMKTBGFQGKQEV-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-hexadecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO NLMKTBGFQGKQEV-UHFFFAOYSA-N 0.000 description 1
- CGEGSCDKJJXMSB-UHFFFAOYSA-N 2-[dodecyl(2-hydroxyethyl)phosphoryl]ethanol Chemical compound CCCCCCCCCCCCP(=O)(CCO)CCO CGEGSCDKJJXMSB-UHFFFAOYSA-N 0.000 description 1
- DSNJGFLHEVDMHH-UHFFFAOYSA-N 2-dodecoxy-n,n-dimethylethanamine Chemical compound CCCCCCCCCCCCOCCN(C)C DSNJGFLHEVDMHH-UHFFFAOYSA-N 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- 229940100555 2-methyl-4-isothiazolin-3-one Drugs 0.000 description 1
- HIAHPXLWIQVPMP-UHFFFAOYSA-N 20-aminoicosane-1,1-diol Chemical compound NCCCCCCCCCCCCCCCCCCCC(O)O HIAHPXLWIQVPMP-UHFFFAOYSA-N 0.000 description 1
- DYNHRNODLOIZQP-UHFFFAOYSA-N 3-dodecoxy-2-hydroxy-n,n-bis(3-hydroxypropyl)propan-1-amine oxide Chemical compound CCCCCCCCCCCCOCC(O)C[N+]([O-])(CCCO)CCCO DYNHRNODLOIZQP-UHFFFAOYSA-N 0.000 description 1
- QOXOZONBQWIKDA-UHFFFAOYSA-N 3-hydroxypropyl Chemical group [CH2]CCO QOXOZONBQWIKDA-UHFFFAOYSA-N 0.000 description 1
- MNMLTWNKYZNOQA-UHFFFAOYSA-N 3-methoxy-1-methylsulfinyltridecane Chemical compound CCCCCCCCCCC(OC)CCS(C)=O MNMLTWNKYZNOQA-UHFFFAOYSA-N 0.000 description 1
- UWQGQQYXWFQSQC-UHFFFAOYSA-N 5-[bis(2-hydroxyethyl)-octadecylazaniumyl]pentanoate Chemical compound CCCCCCCCCCCCCCCCCC[N+](CCO)(CCO)CCCCC([O-])=O UWQGQQYXWFQSQC-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- COVZYZSDYWQREU-UHFFFAOYSA-N Busulfan Chemical compound CS(=O)(=O)OCCCCOS(C)(=O)=O COVZYZSDYWQREU-UHFFFAOYSA-N 0.000 description 1
- OHIPQWBJSYSDGC-UHFFFAOYSA-N C(CCCCCCCCCCCCC)N.OCCOCCO Chemical compound C(CCCCCCCCCCCCC)N.OCCOCCO OHIPQWBJSYSDGC-UHFFFAOYSA-N 0.000 description 1
- VCCWZAQTNBYODU-UHFFFAOYSA-N CC(=C)CC(C)CCC(C)=C Chemical group CC(=C)CC(C)CCC(C)=C VCCWZAQTNBYODU-UHFFFAOYSA-N 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical class S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 206010014979 Epidemic typhus Diseases 0.000 description 1
- 239000004347 Glyceryl monoacetate Substances 0.000 description 1
- 241000258937 Hemiptera Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 241000255777 Lepidoptera Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 239000005949 Malathion Substances 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- GWFGDXZQZYMSMJ-UHFFFAOYSA-N Octadecansaeure-heptadecylester Natural products CCCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCCCC GWFGDXZQZYMSMJ-UHFFFAOYSA-N 0.000 description 1
- REYJJPSVUYRZGE-UHFFFAOYSA-N Octadecylamine Chemical class CCCCCCCCCCCCCCCCCCN REYJJPSVUYRZGE-UHFFFAOYSA-N 0.000 description 1
- 241000118205 Ovicides Species 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 201000000486 Pediculus humanus corporis infestation Diseases 0.000 description 1
- 229920002025 Pluronic® F 88 Polymers 0.000 description 1
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920000289 Polyquaternium Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 101000611641 Rattus norvegicus Protein phosphatase 1 regulatory subunit 15A Proteins 0.000 description 1
- 241000868102 Saccharopolyspora spinosa Species 0.000 description 1
- 108010077895 Sarcosine Proteins 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 241001494115 Stomoxys calcitrans Species 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- PLZVEHJLHYMBBY-UHFFFAOYSA-N Tetradecylamine Chemical compound CCCCCCCCCCCCCCN PLZVEHJLHYMBBY-UHFFFAOYSA-N 0.000 description 1
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 description 1
- 229910052770 Uranium Inorganic materials 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- ZZXDRXVIRVJQBT-UHFFFAOYSA-M Xylenesulfonate Chemical compound CC1=CC=CC(S([O-])(=O)=O)=C1C ZZXDRXVIRVJQBT-UHFFFAOYSA-M 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- NNAKVPGUNQHYEO-UHFFFAOYSA-N [dodecyl(hydroxymethyl)phosphanyl]methanol Chemical compound CCCCCCCCCCCCP(CO)CO NNAKVPGUNQHYEO-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 125000002877 alkyl aryl group Chemical group 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 150000001450 anions Chemical group 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000013011 aqueous formulation Substances 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid group Chemical group C(C1=CC=CC=C1)(=O)O WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000004568 cement Substances 0.000 description 1
- 229940081620 ceteth-2 Drugs 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 210000001520 comb Anatomy 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 239000008271 cosmetic emulsion Substances 0.000 description 1
- 239000002178 crystalline material Substances 0.000 description 1
- ZRKZFNZPJKEWPC-UHFFFAOYSA-N decylamine-N,N-dimethyl-N-oxide Chemical compound CCCCCCCCCC[N+](C)(C)[O-] ZRKZFNZPJKEWPC-UHFFFAOYSA-N 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000002542 deteriorative effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- VKKVMDHHSINGTJ-UHFFFAOYSA-M di(docosyl)-dimethylazanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCCCCCC VKKVMDHHSINGTJ-UHFFFAOYSA-M 0.000 description 1
- UVQMSPMFCMIROL-UHFFFAOYSA-N diazanium propane dichloride Chemical compound [NH4+].[NH4+].[Cl-].[Cl-].CCC UVQMSPMFCMIROL-UHFFFAOYSA-N 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- JXSJBGJIGXNWCI-UHFFFAOYSA-N diethyl 2-[(dimethoxyphosphorothioyl)thio]succinate Chemical compound CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC JXSJBGJIGXNWCI-UHFFFAOYSA-N 0.000 description 1
- XJAKUIIGQJMOHE-UHFFFAOYSA-M dihexadecyl(dimethyl)azanium;acetate Chemical compound CC([O-])=O.CCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCC XJAKUIIGQJMOHE-UHFFFAOYSA-M 0.000 description 1
- NAPSCFZYZVSQHF-UHFFFAOYSA-N dimantine Chemical compound CCCCCCCCCCCCCCCCCCN(C)C NAPSCFZYZVSQHF-UHFFFAOYSA-N 0.000 description 1
- SPCNPOWOBZQWJK-UHFFFAOYSA-N dimethoxy-(2-propan-2-ylsulfanylethylsulfanyl)-sulfanylidene-$l^{5}-phosphane Chemical compound COP(=S)(OC)SCCSC(C)C SPCNPOWOBZQWJK-UHFFFAOYSA-N 0.000 description 1
- REZZEXDLIUJMMS-UHFFFAOYSA-M dimethyldioctadecylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC REZZEXDLIUJMMS-UHFFFAOYSA-M 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- JRBPAEWTRLWTQC-UHFFFAOYSA-N dodecylamine Chemical compound CCCCCCCCCCCCN JRBPAEWTRLWTQC-UHFFFAOYSA-N 0.000 description 1
- SYELZBGXAIXKHU-UHFFFAOYSA-N dodecyldimethylamine N-oxide Chemical compound CCCCCCCCCCCC[N+](C)(C)[O-] SYELZBGXAIXKHU-UHFFFAOYSA-N 0.000 description 1
- GVKAQUUEBRPEMA-UHFFFAOYSA-N dotetracontan-1-amine Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCN GVKAQUUEBRPEMA-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 244000078703 ectoparasite Species 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 208000028104 epidemic louse-borne typhus Diseases 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- NEENSEWRFBUEBZ-UHFFFAOYSA-N formic acid;octadecan-1-amine Chemical compound OC=O.CCCCCCCCCCCCCCCCCCN NEENSEWRFBUEBZ-UHFFFAOYSA-N 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229940083124 ganglion-blocking antiadrenergic secondary and tertiary amines Drugs 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 1
- SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 1
- 229940074046 glyceryl laurate Drugs 0.000 description 1
- 235000019442 glyceryl monoacetate Nutrition 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 229940074050 glyceryl myristate Drugs 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- 150000002337 glycosamines Chemical class 0.000 description 1
- 230000003370 grooming effect Effects 0.000 description 1
- 230000012447 hatching Effects 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- DWMMZQMXUWUJME-UHFFFAOYSA-N hexadecyl octanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCC DWMMZQMXUWUJME-UHFFFAOYSA-N 0.000 description 1
- UQEAIHBTYFGYIE-UHFFFAOYSA-N hexamethyldisiloxane Chemical class C[Si](C)(C)O[Si](C)(C)C UQEAIHBTYFGYIE-UHFFFAOYSA-N 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- RNYJXPUAFDFIQJ-UHFFFAOYSA-N hydron;octadecan-1-amine;chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[NH3+] RNYJXPUAFDFIQJ-UHFFFAOYSA-N 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- BUHXFUSLEBPCEB-UHFFFAOYSA-N icosan-1-amine Chemical compound CCCCCCCCCCCCCCCCCCCCN BUHXFUSLEBPCEB-UHFFFAOYSA-N 0.000 description 1
- ZCTXEAQXZGPWFG-UHFFFAOYSA-N imidurea Chemical compound O=C1NC(=O)N(CO)C1NC(=O)NCNC(=O)NC1C(=O)NC(=O)N1CO ZCTXEAQXZGPWFG-UHFFFAOYSA-N 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229940045996 isethionic acid Drugs 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940094522 laponite Drugs 0.000 description 1
- 229940116335 lauramide Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 150000002678 macrocyclic compounds Chemical class 0.000 description 1
- 229940041033 macrolides Drugs 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229960000453 malathion Drugs 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- BEGLCMHJXHIJLR-UHFFFAOYSA-N methylisothiazolinone Chemical compound CN1SC=CC1=O BEGLCMHJXHIJLR-UHFFFAOYSA-N 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- ONHFWHCMZAJCFB-UHFFFAOYSA-N myristamine oxide Chemical compound CCCCCCCCCCCCCC[N+](C)(C)[O-] ONHFWHCMZAJCFB-UHFFFAOYSA-N 0.000 description 1
- IBOBFGGLRNWLIL-UHFFFAOYSA-N n,n-dimethylhexadecan-1-amine oxide Chemical compound CCCCCCCCCCCCCCCC[N+](C)(C)[O-] IBOBFGGLRNWLIL-UHFFFAOYSA-N 0.000 description 1
- RSVIRMFSJVHWJV-UHFFFAOYSA-N n,n-dimethyloctan-1-amine oxide Chemical compound CCCCCCCC[N+](C)(C)[O-] RSVIRMFSJVHWJV-UHFFFAOYSA-N 0.000 description 1
- 229940049292 n-(3-(dimethylamino)propyl)octadecanamide Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- WWVIUVHFPSALDO-UHFFFAOYSA-N n-[3-(dimethylamino)propyl]octadecanamide Chemical compound CCCCCCCCCCCCCCCCCC(=O)NCCCN(C)C WWVIUVHFPSALDO-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- XPNWIWHUGHAVLC-UHFFFAOYSA-N octadecyl 3-[(3-octadecoxy-3-oxopropyl)disulfanyl]propanoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)CCSSCCC(=O)OCCCCCCCCCCCCCCCCCC XPNWIWHUGHAVLC-UHFFFAOYSA-N 0.000 description 1
- NKBWPOSQERPBFI-UHFFFAOYSA-N octadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCCCC NKBWPOSQERPBFI-UHFFFAOYSA-N 0.000 description 1
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 239000003605 opacifier Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 231100000194 ovacidal Toxicity 0.000 description 1
- 230000003151 ovacidal effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 239000011049 pearl Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 229960000490 permethrin Drugs 0.000 description 1
- RLLPVAHGXHCWKJ-UHFFFAOYSA-N permethrin Chemical compound CC1(C)C(C=C(Cl)Cl)C1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 RLLPVAHGXHCWKJ-UHFFFAOYSA-N 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- XYFCBTPGUUZFHI-UHFFFAOYSA-O phosphonium Chemical compound [PH4+] XYFCBTPGUUZFHI-UHFFFAOYSA-O 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 235000017807 phytochemicals Nutrition 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229930000223 plant secondary metabolite Natural products 0.000 description 1
- 229920000233 poly(alkylene oxides) Polymers 0.000 description 1
- 229920001921 poly-methyl-phenyl-siloxane Polymers 0.000 description 1
- 229920001281 polyalkylene Polymers 0.000 description 1
- 125000003367 polycyclic group Chemical group 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 229940032044 quaternium-18 Drugs 0.000 description 1
- ARIWANIATODDMH-UHFFFAOYSA-N rac-1-monolauroylglycerol Chemical compound CCCCCCCCCCCC(=O)OCC(O)CO ARIWANIATODDMH-UHFFFAOYSA-N 0.000 description 1
- DCBSHORRWZKAKO-UHFFFAOYSA-N rac-1-monomyristoylglycerol Chemical compound CCCCCCCCCCCCCC(=O)OCC(O)CO DCBSHORRWZKAKO-UHFFFAOYSA-N 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 229940043230 sarcosine Drugs 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 150000005619 secondary aliphatic amines Chemical class 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229920005573 silicon-containing polymer Polymers 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- IWMMSZLFZZPTJY-UHFFFAOYSA-M sodium;3-(dodecylamino)propane-1-sulfonate Chemical compound [Na+].CCCCCCCCCCCCNCCCS([O-])(=O)=O IWMMSZLFZZPTJY-UHFFFAOYSA-M 0.000 description 1
- HWCHICTXVOMIIF-UHFFFAOYSA-M sodium;3-(dodecylamino)propanoate Chemical compound [Na+].CCCCCCCCCCCCNCCC([O-])=O HWCHICTXVOMIIF-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- WSWCOQWTEOXDQX-MQQKCMAXSA-N sorbic acid group Chemical group C(\C=C\C=C\C)(=O)O WSWCOQWTEOXDQX-MQQKCMAXSA-N 0.000 description 1
- 229940100515 sorbitan Drugs 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 229940105131 stearamine Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000019635 sulfation Effects 0.000 description 1
- 238000005670 sulfation reaction Methods 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 150000003510 tertiary aliphatic amines Chemical class 0.000 description 1
- 150000003568 thioethers Chemical class 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000583 toxicological profile Toxicity 0.000 description 1
- 201000004364 trench fever Diseases 0.000 description 1
- ABVVEAHYODGCLZ-UHFFFAOYSA-N tridecan-1-amine Chemical compound CCCCCCCCCCCCCN ABVVEAHYODGCLZ-UHFFFAOYSA-N 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 238000001238 wet grinding Methods 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 229940071104 xylenesulfonate Drugs 0.000 description 1
Abstract
Safer pediculicidal formulations comprising a spinosyn, or a physiologically acceptable derivative or salt thereof, and a physiologically acceptable carrier, and methods of controlling lice infestations in a human with these formulations are provided.
Description
FORMULATIONS TO CONTROL LICE IN HUMANS
DESCRIPTION OF THE INVENTION The infestation of the human body by lice is a social and health problem increasingly prevalent in many countries, including the United States. Lice are very small insects (approximately 2-3 mm in length). They deposit eggs in either the hair or the fibers of the cloth and bind them firmly with a
excretion similar to a cement. The eggs usually hatch in about 6 to 10 days, depending on the temperature. The empty shells remaining after the nymphs emerge from the eggs resemble white grains of sand. These shells are
called nits. The order Anoplura or sucking lice are parasites found in or near all groups of mammals. Of the 15 recognized families of Anoplura, two families, Pediculidae and Pthiridae have species that are
find in humans. Pediculus humanus is the only species in the Pediculidae family that infest humans. Includes the head louse, Pediculus humanus capi tis; and the body louse or clothing, Pediculus humanus humanus, sometimes called Pediculus corporis. The
crabs, Pthirus pubis, is a different species and is the Ref: 125586
only member of the Pthiridae family that infest humans. As used herein, the term "human louse or lice" includes a member of the genus Pediculus humanus or Pthirus pubis. 5 Human lice are spread by overcrowding and the common use of clothing and combs. Initially, infestations almost always resulted in irritation, but irritation could cause irritated area infections. There are at least three major diseases that are transmitted mainly by lice: epidemic typhus, trench fever and recurrent fever. Although the human lice varieties are related, each of them has specific characteristics regarding habitat and feeding. For example, head lice are small, hard-bodied ectoparasites that get stuck in the hair as they feed, mate and lay eggs. The louse must remain in the head or die in a short period of time. Head lice proliferate at incredible speed. A louse is ready to mate and reproduce after 10 hours of hatching. Under ideal conditions, a female louse can produce up to 300 eggs during its life. The ideal conditions 25 include an adequate food supply, a
-., ^ ¿^^ > »^ _t. »* Iu ?? f¿ &abA? I *. ~« *. . . ~ ^ G ^ a-Sa.? * YzS g ** ^ "^ - ^^^^ ^ ^ && & < e¿¿ ^ **« * m? T environmental temperature of approximately 28 at approximately 32 ° C and a relative humidity of approximately 70 to 90% Bad hygiene and personal grooming habits are also known to contribute significantly to the spread of head lice, so head lice infestations are serious in geographic areas. where the inhabitants have housing and hygienic practices below normal, however, lice can be a problem even when the conditions are relatively sanitary.The hard chitinous exoskeleton of the louse serves as protection for the external elements. (or ova) are similarly protected by a chitinous pod that surrounds the egg and are attached to the hair.Although lice can be affected by the use of an insecticide, the eggs often remain resistant to attack. an infestac Ion by louse includes both a pediculicide, which kills adult lice, and an ovicide, which interrupts the development of the eggs. Biologically active agents have been used for some time in an attempt to control lice. For example, lindane, gamma-benzene hexachloride), organophosphates (malathion), natural pyrethrins and synthetic compounds known as pyrethroids (such as permethrin) have been used as pediculicides in formulations for the treatment of lice. However, these agents have drawbacks. For example, lindane has a poor safety profile and lice have developed resistance to this substance. Natural pyrethrins require frequent follow-up treatments because they only provide a short-term residual action. Synthetic pyrethroids, although more effective against lice than natural pediculicides, are often more toxic to the subject being treated. Spinosyns (also known as factors A83453) are agricultural insecticides that have shown activity against 1) cuncunilla of chargas and other insects of the order Lepidoptera, 2) louse of cotton and other members of the order Homoptera and 3) stable fly, blue fly of meat and mosquitoes, which are members of insect order Diptera (see U.S. Patent No. 5,362,634, infra). Spinosyn A has an excellent safety for humans and animals and an excellent toxicological profile. The present invention relates to formulations for controlling infestation by lice in a human being, comprising a spinosyn or a physiologically acceptable salt or derivative thereof and a physiologically acceptable carrier. The present invention further relates to methods for controlling an infestation by lice in a human being, comprising the topical administration to humans, of an amount of a spinosyn or a physiologically acceptable derivative / salt thereof, which controls the lice. The formulations and methods of the present invention are safer and more effective than those currently available. A particular benefit of the formulations is their effectiveness against lice species that have become resistant to the products currently used. The preferred formulations and methods of the present invention are hair care formulations, such as shampoos, lotions and conditioners, and methods for the use of these hair care formulations, to control an infestation by lice in a human being. Especially useful pediculicidal / ovicidal (anti-louse) formulations of the present invention are hair care formulations. Especially useful hair care formulations are shampoos. In another aspect, the present invention provides the use of a spinosyn, or a physiologically acceptable salt or derivative thereof, or a formulation
which contains either a spinosyn or a derivative or salt thereof, for the manufacture of a medicament for controlling lice in a human being. The term "controlling an infestation by lice" as used herein, refers to the treatment of an active lice infestation or the prevention of an infestation in a human being who is likely to be exposed to a lice infestation. Spinosyns are fermentation products of natural origin. These are macrolides produced by the cultivation of Saccharopolyspora spinosa. The fermentation produces multifactors, including spinosyn A and spinosyn D (also called A83543A and A83543D). Spinosyn A and spinosyn D are two spinosyns that are most active as insecticides. A product comprised primarily of these two spinosyns (approximately 85% A and 15% D) is commercially available from Dow Agrosciences under the trade name spinosad. The name "spinosad" comes from a contraction of spinosyns "A" and "D". Each spinosyn has a 12-membered macrocyclic ring that is part of an unusual tetracyclic ring system to which two different sugars are attached, the amino sugars forosamine and the neutral sugar 2N, 3N, 4N-tri-0-methyl-rhamnose. This unique structure sets apart the spinosyns from the other macrocyclic compounds. Spinosyn A (A83543A) was the first isolated and identified spinosyn from the fermentation broth of Saccharapolyspora spinosa. Subsequent examination of the fermentation broth revealed that the progenitor strain of S. spinosa produced a number of spinosyns, which were designated from A to J (A83543A to J). Compared to spinosyn A, spinosyns B-J are characterized by differences in the amino group substitution patterns of the forosamine, in selected sites of the tetracyclic ring system and in 2N, 3N, 4N-tri-0-methylrimanose. The strains of S. spinosa currently in use produce a mixture of spinosyns from which the primary components are spinosyn A (~ 85%) and spinosyn D (~ 15%). Additional spinosyns have been identified, which were assigned the letters from K to W, from mutant strains of S. spinosa. The term "spinosyn or a derivative thereof" as used herein, refers to an individual spinosy factor (A, B, C, D, E, F, G, H, J, K, L, M , N, O, P, Q, R, ST, U, V, W or Y), a N-desmethyl derivative of an individual spinosyne factor or a combination thereof. For convenience, the term "component
? ÚSJUr tp a & fliw - - - »& -. > "J & 8fc"; "M_" spinosyn "will also be used herein to refer to an individual spinosyn or a physiologically acceptable salt or derivative thereof, or a combination thereof 5 Boeck et al. described the spinosynes AH and J (which he named factors A83543 A, B, C, D, E, F, G, H and J) and salts thereof, in US Pat. Nos. 5,363,634 (issued November 8) 1994), 5,496,932 (issued March 5, 1996), and 5,571,901
(issued November 5, 1996). Mynderse et al. described the spinosyns L-N (which they called factors A83543 L, M and N), their N-demethyl derivatives and salts thereof, in US Pat. No. 5,202,242 (issued April 13, 1993); and Turner et
a. described the QT spinosyns (referred to as factors A83543 Q, R, S and T), their N-demethyl derivatives and salts thereof, in US Pat. Nos. 5,591,606 (issued January 7, 1997) and 5,631,155 ( issued on May 29, 1997). These
patents are incorporated herein by reference. Spinosyns K, O, P, U, V, W and Y are described, for example, in Cari V. DeAmicis, James E. Dripps, Chris J. Hatton and Laura I. Karr in American Chemical Society's Symposium Series: Phytochemicals for Pest Control, Chapter 11,
"Physical and Biological Properties of Spinosyns: Novel
Macrolide Pest-Control Agents from Fermentation ", pages 146-154 (1997) Spinosynes can react to form salts Salts that are physiologically acceptable are also useful in the formulations and methods of the present invention. standard procedures for the preparation of salts For example, spinosyn A can be neutralized with an appropriate acid to form an acid addition salt.
Acid addition salts of the spinosyns are particularly useful. Representatives of such acid addition salts include salts formed by the reaction of an organic or inorganic acid such as, for example, sulfuric, hydrochloric, phosphoric, acetic acid,
Succinic, citric, lactic, maleic, fumaric, colic, pamoic, mucic, glutamic, camphoric, glutaric, glycolic, italic, tartaric, formic, lauric, stearic, salicylic, methanesulfonic, benzenesulfonic, sorbic, picric, benzoic, cinnamic and the like . In addition to the spinosyn component, the formulations of the present invention may include one or more compounds having activity against lice, such as for example synthetic pyrethroids, natural pyrethrins and lindane. All relationships, percentages and
parts described herein, are given "by weight" unless otherwise specified. The anti-lice formulations of the present invention can be formulated in a number of ways. Particularly useful formulations are shampoos, conditioners and lotions. These formulations optionally also comprise one or more of the following: a) a surfactant; b) from about 1 to about 10% of a non-volatile silicone material; and / or c) from about 0.5 to about 5% of a suspending agent. The shampoo formulations of the present invention comprise a spinosyn or a physiologically acceptable salt or derivative thereof, together with water, a surfactant and an amide, and optionally may comprise another anti-louse agent, a silicone compound, a suspending agent and others. Cosmetically acceptable components. Human hair becomes dirty due to contact with the surrounding atmosphere and the accumulation of sebum secreted by the head. When the hair gets dirty, it has a dirty feeling and an unattractive appearance. The shampoo formulations of the present invention both clean the hair and effectively control lice infestation.
- li ¬
when used in a shampoo formulation, the spinosyn component is present in an amount of from about 0.1 to about 30%, preferably from about 1 to about 10%. The surfactants suitable for use in these formulations can be any of a wide variety of synthetic anionic, amphoteric, zwitterionic and nonionic surfactants. Surfactants are generally present in shampoo formulations in
amounts of about 5 to about 30%, preferably about 15 to about 25%. Examples of synthetic anionic surfactants are the alkali metal salts of organic sulfuric reaction products having an alkyl radical which
contains from 8 to 22 carbon atoms and an ester radical of sulfonic acid or sulfuric acid (in the term alkyl the alkyl portion of the higher acyl radicals is included). Sodium, ammonium, potassium or triethanolamine alkyl sulfates are preferred, especially those
obtained by sulfation of higher alcohols (from 8 to 18 carbon atoms); monoglycerides sulfates and sodium sulfonates of coconut oil fatty acid; Sodium or potassium salts of sulfuric acid esters of the reaction product of 1 mole of a fatty alcohol
Higher (e.g., tallow alcohol or alcohol of
coconut) with one to 12 moles of ethylene oxide, the sodium or potassium salts of alkylphenoletylene oxide ether sulfate having 1 to 10 ethylene oxide units per molecule and wherein the alkyl radicals contain from 8 to 12 carbon atoms; sodium alkyl glyceryl ether sulfonates, the product of the reaction of fatty acids having from 10 to 22 carbon atoms esterified with isethionic acid and neutralized with sodium hydroxide; and water-soluble salts of condensation products of fatty acids with sarcosine. Examples of zwitterionic surfactants are derivatives of aliphatic quaternary ammonium, phosphonium and sulfonium compounds, wherein the aliphatic radicals can be straight or branched chain and wherein one of the aliphatic substituents contains from 8 to 18 carbon atoms and one contains a water-solubilizing anionic group, eg, carboxy, sulfonate, sulfate, phosphate or phosphonate. A general formula for these compounds is:
wherein R) 2 contains an alkyl, alkenyl or hydroxyalkyl radical of from about 8 to about 18
carbon atoms, from 0 to about 10 portions of ethylene oxide and from 0 to 1 glyceryl portions; And it is a nitrogen, phosphorus or sulfur atom; R3 is an alkyl or monohydroxyalkyl group of 1 to about 3 carbon atoms; x is 1 when Y is sulfur and 2 when Y is nitrogen or phosphorus; R 4 is an alkylene or hydroxyalkylene radical of 1 to about 4 carbon atoms and Z is a carboxylate, sulfonate, sulfate, phosphonate or phosphate radical. Some examples include: 4- [N, N-di (2-hydroxyethyl) -N-octadecylammonio] -butane 1-carboxylate; 5- [S-3-hydroxypropyl-S-hexadecylsulfonium] -3-hydroxypentane-1-sulfate; 1-phosphate of 3- [P, P-diethyl-P-3,6,9-trioxatetradexocylphosphonium] -2-hydroxypropane; 1-phosphate of 3- [N, N-dipropyl-N-3-dodecoxy-2-hydroxypropylammonio] -propane; 3- (N, N-dimethyl-N-hexadecylammonium) -propane-1-sulfonate; 3- (N, N-dimethyl-N-hexadecylammonium) -2-hydroxypropane-1-sulfonate; N, N-di (2-hydroxyethyl) -N- (2-hydroxydecyl) -ammonium] -butane-1-carboxylate;
1-phosphate of 3- [S-ethyl-S- (3-dodecoxy-2-hydroxypropyl) -sulfonium] -propane; 1-phosphonate 3- [P, P-dimethyl-P-dodecylphosphonium] -propane; and 5- (N, N-di- (3-hydroxypropyl) -N-hexadecylammonium] -2-hydroxypentane-1-sulfate Other zwitterionic surfactants, such as betaines, are also useful in the formulations of the present invention. examples of betaines include the higher alkyl betaines, such as cocodimethylcarboxymethyl betaine, lauryldimethylcarboxymethyl betaine, lauryldimethyl-alpha-carboxyethyl betaine, cetyldimethylcarboxymethyl betaine, lauryl-bis- (2-hydroxyethyl) -carboxymethyl betaine, stearyl-bis- (2-hydroxypropyl) -carboxymethyl betaine, oleyldimethyl-gamma-carboxypropyl betaine and lauryl-bis- (2-hydroxypropyl) -alpha-carboxyethyl betaine The sulfobetaines can be represented by cocodimethylsulfopropyl betaine, stearyldimethylsulfopropyl betaine, lauryldimethylsulfoethyl-betaine, lauryl-bis- (2- hydroxyethyl) -sulfopropyl betaine and the like Amidobetaines and amidosulfobetaines, wherein a radical RCONH (CH2) 3 is attached to the nitrogen atom of betaine, also they are useful in the formulations of the present invention.
Examples of amphoteric surfactants that can be used in the formulations of the present invention are those derived from secondary or tertiary aliphatic amines, wherein the aliphatic radical is straight or branched chain and wherein one of the aliphatic substituents contains about 8 to about 18 carbon atoms and one contains an anionic water-solubilizing group, eg carboxy, sulfonate, sulfate, phosphate or phosphonate. Examples of surfactants
Amphoteric acids are sodium 3-dodecylaminopropionate, sodium 3-dodecylaminopropane sulfonate, N-alkyltaurines such as that prepared by reacting N-dodecylamine with sodium isothionate (see US Pat. No. 2,658,072, Example 3), alkyl aspartic acids N-15 above (see US Patent No. 2,438,091) and products sold under the trade name "Miranol" and which are described in US Patent No. 2,528,378. Nonionic surfactants, which are preferably used in combination with an anionic surfactant,
amphoteric or zwitterionic, are compounds produced by the condensation of alkylene oxide groups (hydrophilic in nature) with an organic hydrophobic compound, which may be aliphatic or alkylaromatic in nature. Some examples of nonionic surfactants include:
1) Polyethylene oxide condensates of alkyl phenols, e.g., the condensation products of alkylphenols having an alkyl group containing from about 6 to 12 carbon atoms in a
The configuration is either linear, or chain branched, with ethylene oxide, wherein the ethylene oxide is present in amounts of 10 to 60 moles of ethylene oxide for each mole of alkylphenol. The alkyl substituent in these compounds can be derived from polymerized propylene, diisobutylene, octane or unborn, for example. 2) Condensates of ethylene oxides with a product of the reaction of propylene oxide with ethylenediamine products, which may have various formulations depending on the desired balance between the
hydrophobic and hydrophilic elements. For example, compounds containing from about 40 to about 80% polyoxyethylene by weight and having a molecular weight of from about 5,000 to about 11,000 resulting from the reaction of
ethylene oxide groups with a hydrophobic base comprising the reaction product of ethylenediamine with an excess of propylene oxide and having a molecular weight in the order of 2,500 to 3,000 are satisfactory. 3) The product of the condensation of aliphatic alcohols having 8 to 18 carbon atoms, either
-ssa * á *)? ái * A ~?! *. ^^? ^ 9sm? A ^^ & r ^ £ ^ iSisr & kZii- & .--; ^ 7 - li ¬
in a straight or branched chain configuration, with ethylene oxide, eg, an ethylene oxide of condensed coconut alcohol having from 10 to 30 moles of ethylene oxide for each mole of coconut alcohol, wherein the fraction of Coconut alcohol has 10 to 14 carbon atoms. 4) Long chain tertiary amine oxides corresponding to the following general formula:
R1RZR3 - + • O wherein Ri contains an alkyl, alkenyl or monohydroxyalkyl radical of from about 8 to about 18 carbon atoms, from 0 to about 10 portions of ethylene oxide and from 0 to 1 glyceryl portions, and R2 and R3 contain from 1 to about 3 carbon atoms and
from 0 to about 1 hydroxy groups, e.g., methyl, ethyl, propyl, hydroxyethyl or hydroxypropyl. The arrow in the formula represents a semipolar link. Some examples of amine oxides suitable for use in the formulations of the present invention, include
dimethyldodecylamine oxide, oleyl-di- (2-hydroxyethyl) -amine oxide, dimethyloctylamine oxide, dimethyldecylamine oxide, dimethyltetradecylamine oxide, 3, 6, 9-trioxaheptadecyldietylamine oxide, di (2-hydroxyethyl) oxide tetradecylamine, 2-oxide
dodecoxyethyldimethylamine, 3-dodecoxy-2-hydroxypropyl-di- (3-hydroxypropyl) -amine oxide and dimethylhexadecylamine oxide. 5) Long chain tertiary phosphine oxides of the following general formula:
RRRfc 0 wherein R contains an alkyl, alkenyl or monohydroxyalkyl radical of about 8 to 18 carbon atoms, from 0 to about 10 ethylene oxide portions and from 0 to 1 glyceryl portions, and R 'and Rn are each an alkyl group or monohydroxyalkyl containing from 1 to 3 carbon atoms. The arrow in the formula represents a semipolar link. Examples of suitable phosphine oxides include: dodecyldimethylphosphine oxide, tetradecyldimethylphosphine oxide, tetradecylmethylethylphosphine oxide, 3, 6, 9-trioxaoctadecyldimethylphosphine oxide, cetyl dimethylphosphine oxide, 3-dodecoxy-2-hydroxypropyl-di- (2- hydroxyethyl) -phosphine, stearyldimethylphosphine oxide, cetylethylpropylphosphine oxide, oleyldiethylphosphine oxide, dodecyldiethylphosphine oxide, tetradecyldiethylphosphine oxide, dodecyldipropylphosphine oxide, dodecyl
di (hydroxymethyl) -phosphine, dodecyldi (2-hydroxyethyl) -phosphine oxide, tetradecylmethyl-2-hydroxypropylphosphine oxide, oleyldimethylphosphine oxide, 2-hydroxydedecyldimethylphosphine oxide. 6) Long chain dialkyl sulfides containing a short chain alkyl radical or a hydroxyalkyl radical of 1 to 3 carbon atoms (usually methyl) and a long chain hydrophobic radical containing alkyl, alkenyl, hydroxyalkyl or ketoalkyl radicals of about 8 to about 20 carbon atoms, from about 0 to about 10 portions of ethylene oxide and from 0 to 1 glyceryl portions. Some examples include: octadecylmethylsulfoxide, 2-ketothrecylmethylsulfoxide, 3,6,9-trioxaoctadecyl-2-hydroxyethyl sulfoxide, dodecylmethylsulfoxide, oleyl-3-hydroxypropylsulfoxide, tetradecylmethylsulfoxide, 3-methoxytridecylmethylsulfoxide, 3-hydroxytridecylmethylsulfoxide and 3-hydroxy-4-dodecoxybutylmethylsulfoxide. Numerous additional non-soap surfactants are described in McCutcheon's Detergents and Emulsifiers, 1998 annual, published by M.C. Publishing Company, Inc .; McCutcheon Division, 175 Rock Rd., Glen Rock, NJ, 07425, U.S.A.
~ ¿& £ fassiaE * r. ~ L. a ^ - ^ • sa ^; * ^. -. ,. The anionic surfactants, particularly the alkyl sulfates, ethoxylated alkyl sulfates and mixtures thereof, as well as the amidobetaines are preferred for use in the shampoo formulations of the present invention. The amides increase the foaming of the formulations by emulsifying the components of the shampoo and the active component (s). The amides used in the present formulations can be any of the fatty acid alkanolamides known to be used in shampoos. These are usually monoethanolamides and fatty acid diethanolamides having from about 8 to about 14 carbon atoms, other suitable amides are those having multiple ethoxy groups, such as PEG-3 lauramide. In shampoo formulations, the amide is generally present at a level of from about 1 to about 7%, preferably from about 2 to about 5% of the formulation. Preferred amides are coconut monoethanolamide, coconut diethanolamide and mixtures thereof. The shampoo formulations of the present invention also contain water. Water is typically present in the shampoos at levels of from about 50 to about 80%, preferably from about 60 to about 75%. After adding water, the relative viscosity of the formulation generally ranges from about 4,000 to about 25,000 centipoise (cp), preferably from about 4,000 to about 12,000 cp, more preferably from about 4,000 to about 5,500 cp, measured at 1 rpm at 26.7 ° C for 3 minutes, using a Wells-Brookfield viscometer, model DV-CP-2 DVII, or Cone model CP-41. The viscosity modifiers and
Hydrotropes can be included to give the formulation a viscosity within these ranges. Shampoo formulations may also include one or more optional components, such as silicone compounds, suspending agents and components that cause
the formulation is cosmetically more acceptable. The silicone compounds condition the hair and facilitate the removal of dead lice, their eggs and nits. Non-volatile silicone materials are used at levels of approximately 1 to
approximately 10% of the formulations. Examples of useful silicone compounds are those described in U.S. Patent No. 5,292,504 to Cardin et al., Issued March 8, 1994, which is incorporated herein by reference.
i rfg-. & amp; amp; amp; & amp; & amp; < RTI > Compounds containing non-volatile silicones are preferred and are used at levels of from about 0.1 to about 10%, preferably from about 0.25 to about 3% by weight of the formulation . Examples of non-volatile silicones are polyalkylsiloxanes, polyalkylarylsiloxanes, polyethersiloxane copolymers and mixtures thereof. Useful polyalkylsiloxanes include, for example, polydimethylsiloxanes (PDMS) with viscosities ranging from about 5 to 15,000,000 cp at 25 ° C. These siloxanes are available, for example, in the General Electric Company as the Viscasil series and in Dow Corning as the Dow Corning 200 series. The viscosity can be measured by means of a glass capillary viscometer, as established in the method of test of Dow Corning Corporation CTM0004, July 20, 1970. Useful polyalkylaryl siloxanes include polymethylphenylsiloxanes having viscosities from about 5 to about 15,000,000 cp at 25 ° C. These siloxanes are available, for example, in General Electric Company as the SF 1075 methylphenyl fluid or in Dow Corning as 556 Cosmetic Grade Fluid. Polyethersiloxane copolymers include polydimethylsiloxanes modified with polypropylene oxide (available, for example, in Dow Corning as DC-1248),
ethylene oxide or mixtures of ethylene oxide and propylene oxide. Insoluble in water are more useful. The siloxanes are able to condition the hair due to its ability to lubricate the hair, providing benefits for wet and dry combing. Higher molecular weight viscous siloxanes provide the best conditioning benefits and, therefore, are preferred. The fluids and gums of the siloxane polymers are the most desirable. Siloxane polymer gums are rigid as opposed to a liquid or fluid, with high molecular weight of about 200,000 to about 1,000,000 and with viscosities of about 100,000 to about 150,000,000 cp at 25 ° C. Such gums are described in U.S. Patent No. 5,292,504 (supra). Suspending agents can be included to improve long-term stability. Useful suspending agents include fatty amphiphilic crystalline materials having needle-like structures or platelets, polymeric materials, clays, fuming metal oxides and mixtures thereof. These agents are known in the art (see U.S. Patent No. 5,292,504). Suitable crystalline amphiphilic materials are those having needle or type structures
.nuaS ^ m ^ mt ^ wK .. ^ MEs ^ - ^ atÉas - platelet. Such compounds include long chain acyl derivatives (from 16 to 22 carbon atoms) such as ethylene glycol esters of fatty acids (e.g. ethylene glycol distearate); long chain alkanolamides (16 to 22 5 carbon atoms) of fatty acids, such as stearamide MEA, stearyl stearate and distearyl dithiopropionate; and mixtures thereof. Polymeric materials that are useful as suspending agents include polycyclic acids
crosslinked (such as the Carbopol series, available from B.F. Goodricch Chemical Company), guara gum and its derivatives, xanthan gum, crosslinked ethylene / maleic anhydride copolymers and mixtures thereof. The clays and oxides of smoky metals also
are effective as suspending agents. Some examples include magnesium and aluminum silicates (such as the Veegum series, available from R. T. Vanderbilt Company, Inc.), sodium and aluminum silicates (such as the Laponite series, available from Laponite, United States), silica
smokers, fuming alumina, fuming titania and mixtures thereof. In the shampoo formulations of the present invention, the suspending agents are generally present in amounts of about 0.5 to
about 5%, preferably from 0.5 to about
- < afe ** .- * -, * ~. ^ ^ * - "*? *» ¿^ & 3i? tf? * &'' & ** > *! and *, 3%. Long chain acyl derivatives such as ethylene glycol esters of fatty acids are preferred. The most preferred one is ethylene glycol distearate. Other optional components can improve the cosmetic acceptability of the formulations, which are known in the art and include, for example, preservatives such as methylparaben, propylparaben, methylisothiazolinone and imidazolidinyl urea; Thickening agents and viscosity modifiers such as
amine oxides, block polymers of ethylene oxide and propylene oxide (such as Pluronic F88 marketed by BASF Wyandotte), fatty alcohols (such as cetearyl alcohol), sodium chloride, ammonium chloride, sodium sulfate, polyvinyl alcohol , propylene glycol and alcohol
ethyl; hydrotropes such as xylene sulfonate, pH adjusting agents such as citric acid, succinic acid, phosphoric acid, sodium hydroxide and sodium carbonate; perfumes, dyes, quaternary ammonium compounds, such as Polyquaternium 41, agents
sequestrants such as disodium ethylenediaminetetraacetate; and pearlizing agents such as ethylene glycol distearate acid ester, stearic acid diesters and polyethylene glycol palmitic acid and stearic acid monoethanolamide. Generally these optional components
set individually used at a level of about 0.1 to about 10% of the formulation. The shampoo formulations of the present invention are used in a conventional manner to clean the hair. About 10 to about 30 g of the formulation are applied to the wet hair and it is well spread throughout the hair and scalp. The formulation is left on the hair and scalp for about 6 to 10 minutes and then removed by rinsing. This process is repeated until the hair is clean.
lindane These conditioning formulations can also be used effectively for the treatment of lice infestation. Hair conditioners are products that improve the look, feel and manageability of hair. Conditioners are particularly important when the hair has been damaged by treatments such as application of permanent waving, drying, mistreatment and discoloration, or by atmospheric conditions such as sunlight, which cause photocatalyzed oxidation. These factors can cause the hair to have a poor texture, making it difficult to handle and comb it, whether dry or wet. When used in a hair conditioner formulation, the spinosyn component is present at a level of from about 0.1 to about 30%, preferably from about 1 to about 10%. Conditioning products are well known and include "rinse-type" products, which are rinsed off shortly after being applied to clean hair and "deep conditioners" which remain in the hair for extended periods of time. A group of conditioners useful in the hair conditioner formulations of the present invention are long-chain quaternary ammonium compounds combined with lipid materials, such as fatty alcohols (see US Patent No. 3,155,591 to Hilfer, issued March 3, 1995). November 1964 and 5 US Patent No. 4,269,824 to Villamarin et al., issued May 26, 1981). Another group of conditioners are lipid and quaternary ammonium compounds. These conditioners are used to form gel-type conditioning products that have
good cosmetic and rheological characteristics during use. These types of gel-like formulations are generally described in the following documents: Barry, "The Self Bodying Action of the Mixed Emulsifier Sodium Docecil Sulfate / Cetyl Alcohol", J. of Colloid and Interface
Science, 28, 82-91 (1968 (; Barry et al., "The Self-Bodying
Action of Alkyltrimethylammonium Bromides / Cetostearyl
Alcohol Mixed Emulsifiers; Influence of Quarternary Chain
Length ", J. of Colloid and Interface Science, 35, 689-708 (1971 (, and Barry et al.," Rheology of Systems Containing
Cetomacrogo / 1000 - (cetostearyl alcohol), I. Self-Bodying Action, "J. of Colloid and Interface Science, 38, 616-625 (1972) .The lipid materials used in these conditioners are present at a level of
about 0.5 to about 3%. These lipids
they are essentially insoluble in water and contain hydrophobic and hydrophilic portions. These include materials derived from natural and synthetic fatty acids which are selected from the group consisting of acids, acid derivatives, alcohols, esters, ethers, ketones, amides and mixtures thereof, having alkyl chain lengths of about 12 to about 22 carbon atoms, preferably 16 to 18 carbon atoms in length. Fatty alcohols and fatty esters are preferred. Useful fatty alcohols are known (see, for example, U.S. Patent No. 3,155,591, supra; U.S. Patent No. 4,165,369 (Watanabe et al., Issued May 26, 1981); British Patent Specification No. 1,532,585, published November 15, 1978; Fukushima et al., "The Effect of Cetostearyl Alcohol in Cosmetic Emulsions", Cosmetics & Toiletries, 98, 89-102 (1983); and Hunting, Enclyclopedia of Conditioning Rinse Ingredients, in 204 (1987). Fatty alcohols are alcohols of 12 to 16 carbon atoms which are selected from the group consisting of cetearyl alcohol, cetyl alcohol, isostearyl alcohol, lanolin alcohol, lauryl alcohol, oleyl alcohol, stearyl alcohol and mixtures thereof. Preferred are cetyl alcohol, stearyl alcohol and
«.-. Y-.g- ~ S ?? XYí? -:., -..- •, - .. * yy.y.i -. -. . -, - ,. ^ ¿-X¿ü * 3zMjSÉJ & > .sY? mixtures thereof. A particularly preferred fatty alcohol is comprised of a mixture of cetyl alcohol and stearyl alcohol containing from about 55 to about 65% (by weight of the mixture) of cetyl alcohol. Useful fatty esters are also known (see Kaufman et al., U.S. Patent No. 3,341,465, issued September 12, 1967). Fatty esters are fatty acids in which the active hydrogen has been replaced by the alkyl group of a monohydric alcohol. The monohydric alcohols are fatty alcohols as described, supra. Fatty esters useful in these conditioner formulations include cetyl lactate, cetyl octanoate, cetyl palmitate, cetyl stearate, glyceryl monostearate, glyceryl laurate, glyceryl myristate, glyceryl oleate, glyceryl stearate, glyceryl monoacetate. and mixtures thereof. Cetyl palmitate and glycerol monostearate or mixtures thereof are preferred. Cationic surfactants can be used in these conditioner formulations, either alone or in combination, generally in an amount of about 0.1 to about 5% of the final formulation. These surfactants contain amino or
feá = i. -B ^ »-» faith < Hydrophilic quaternary ammonium having positive charge when dissolved in the aqueous formulations of the present invention. These cationic surfactants are known in the art (see McCutcheon's Detergents &Emulsifiers, supra, Schwartz et al., Surface Active Agents, Their Chemistry and Technology, New York: Interscience Publishers, 1949, US Patent No. 3,155,591, supra, US Pat. No. 3,929,678 (Laughiin et al., Issued December 30, 1975), US Patent No. 3,959,461 (Bailey et al., Issued May 25, 1976), and US Patent No. 4,387,090 (Bolich, Jr., Issued June 7, 1983.) Useful quaternary ammonium cationic surfactant materials are those of the general formula:
wherein Ri is a hydrogen atom, an aliphatic group of 1 to 22 carbon atoms or an aromatic, aryl or alkylaryl group having from 12 to 22 carbon atoms; R2 is an aliphatic group of 1 to 22 carbon atoms; R3 and R4 are each alkyl groups of 1 to 3 carbon atoms and X is an anion selected from the group consisting of halogen, acetate, phosphate, nitrate and alkyl sulfate.
^^ iS ^ ^^^. ^^^ ¡^ S ^^ Aliphatic groups may contain bonds and other groups such as amido groups, in addition to carbon and hydrogen atoms. Other useful quaternary ammonium salts have the formula: R2 R4 ++ R N- (CH2) 3-f ^ 6 2X R3 Rs wherein at least one, but not more than 3 of the R groups is an aliphatic group having from 16 to 22 carbon atoms and the remaining R groups are selected from the group
Which consists of hydrogen atoms and alkyl radicals of 1 to 4 carbon atoms, and X is an ion selected from the group consisting of halogen, acetate, phosphate, nitrate and alkyl radicals. Sebacic propane diammonium dichloride is an example of this type of salt
quaternary ammonium. The quaternary ammonium salts useful herein also include the dialkyldimethylammonium chlorides, wherein the alkyl groups have from 12 to 22 carbon atoms. These alkyl groups are
can be derived from long chain fatty acids, such as hydrogenated tallow fatty acid. The tallow fatty acid gives rise to quaternary compounds where Ri and R2
they predominantly have 16 to 18 carbon atoms. Examples include ditallowdimethylammonium chloride, ditallowdimethylammonium methylisulfate, dihexadecyldimethylammonium chloride, di (hydrogenated tallow) -dimethylammonium chloride, dioctadecyldimethyl-ammonium chloride, diemyldimethylammonium chloride, didocosyldimethylammonium chloride, di (hydrogenated tallow) -dimethylammonium acetate, dihexadecyldimethylammonium chloride, dihexadecyldimethylammonium acetate, disodium propylammonium phosphate, ditallowdimethylammonium nitrate, di (alkyl-coconut) -dimethylammonium chloride and stearyldimethyl-benzylammonium chloride. Preferred quaternary ammonium salts useful herein include ditallowdimethylammonium chloride, dicetyldimethylammonium chloride, stearyldimethylbenzyl ammonium chloride, cetyltrimethylammonium chloride, tricetylmethylammonium chloride, and mixtures thereof. Di (hydrogenated tallow) -dimethylammonium chloride (Quaternium-18) is a particularly preferred quaternary ammonium salt and is available from Sherex Chemical Company, Inc. under the names Adogen 442 and Adogen 442-100P. Salts of primary, secondary and tertiary fatty amines can also be used as cationic surfactant. Alkyl groups of such amines preferably have from 12 to 22 carbon atoms and may or may not be substituted. Secondary and tertiary amines are preferred; and tertiary amines are particularly preferred. Examples of useful amines include stearamidopropyldimethylamine, diethylaminoethyl-5-stearamine, dimethylstearamine, dimethyloxyamine, soyamine, myristylamine, tridecylamine, ethylstearylamine, N-sebopropanediamine, ethoxylated stearylamine) 5 moles of ethylene oxide), dihydroxyethylstearylamine and arachidylbehenylamine. The right amine salts
include the halogen, acetate, phosphate, nitrate, citrate, lactate and alkyl sulfate salts. Some examples include stearylamine hydrochloride, soyamine chloride, stearylamine formate, N-sebopropanediamine dichloride, and stearmidopropyldimethyl-15-amine citrate. Useful cationic amine surfactants are also described in U.S. Patent No. 4,275,055 (Nachtigal et al., Issued June 23, 1982). Water is an essential ingredient in conditioning formulations. Water is added in the
The last stage of the preparation of the conditioner, using an amount sufficient to bring the mixture (c.b.p.) to 100%. The optional ingredients in the conditioner formulations include conditioning agents for
silicone that can be used for their characteristics
igj «w ^ i¿ ^ * ^ ± y-Jága ^^^^» > ^ 2 ^, ^. »-r- ^ SfesS l§ife? Ii¡Mfea '-«, - jMiM¡ -a, < > & * • »« .fcgguafe cosmetic and rheological. Silicone oils and silicone polymers are well-known conditioning agents. For example, volatile silicones, organilicone polymers in water-alcohol mixtures and volatile silicone fluids are described in US Pat. No. 5,292,502 supra. The formulation may include one or more silicones of those described for use in the shampoo formulations, supra. These silicones include volatile and non-volatile polyalkylsiloxanes, polyalkylarylsiloxanes and mixtures thereof. These can be used in amounts of about 0.2 to about 5% of the final formulation. As with shampoos, the higher viscosity silicone gums of the siloxanes described above are preferred. These gums are rigid, as opposed to fluids, with high molecular weights of about 200,000 to about 1,000,000 and viscosities of about 100,000 to about 20,000,000,000 cp, at 25 ° C. Most preferred are polydimethylsiloxane gums. A significant amount of the lipid material of the conditioner is often deposited on the hair, leaving it greasy. Therefore, the conditioner formulations may incorporate silicone copolyols
^ Y - ^? ? ^ ^ -S¿ ^^^^? ^^^^ ¿, -s ^ ^ ^ ^ ^ ^ ^ S ^ - to provide optimal conditioning benefits with lice treatment. See European Patent Application 155,806, published September 25, 1985. 5 Silicone copolyols are dimethyl polysiloxanes modified with polyalkylene oxide, referred to herein as "dimethicone copolyols", which act as emulsifiers and reduce the deposition of vehicle materials (materials
lipids and / or cationic surfactants) on the hair. Useful dimethicone copolyols are also described in U.S. Patent No. 5,292,504, supra. The silicone copolyol is generally present in an amount of about 0.1 to about
10%, preferably from about 0.1 to about 2% of the final formulation. Dimethicone copolyols are preferred for this use. Dow Corning 190 silicone surfactant is a preferred dimethicone copolyol. 20 The formulations may also contain components that modify the physical and performance characteristics of the conditioning product. Such components include additional surfactants, salts, buffer solutions, thickeners, solvents, opacifiers,
pearl agents, preservatives, fragrances, dyes,
dyes, pigments, chelants, sunscreens, vitamins and medicinal agents. Examples of these types of components are described in U.S. Patent No. 4,387,090 (Bolich, Jr., issued June 7, 1983). The formulations may also contain optional surfactant materials in amounts such that the total level of surfactant present in the formulation (including the cationic surfactant carrier material, described supra) is from about 0.05 to about 5%. These optional surfactant materials may be anionic, non-ionic or amphoteric. some examples are ceteareth-20, steareth-20, sorbitan monoesters, sodium tallowalkylsulfate and sebo-betaine. Optional surfactant materials are described in McCutcheon's Detergents &; Emulsifiers, supra; Schwarts et al., Supra; and in U.S. Patent No. 3,929,678 supra. The preferred optional surfactant materials are non-ionic. Such surfactants are commonly produced by the condensation of an alkylene oxide (hydrophilic in nature) with an organic hydrophobic compound; that is, normally of aliphatic or alkylaromatic nature. The length of the hydrophilic or polyalkylene portion that condenses with any compound
Particular hydrophobic, can be adjusted to obtain a water-soluble compound that contains the desired degree of balance between the hydrophilic and hydrophobic elements. Such nonionic surfactants include the condensates of alkylphenols with polyethylene oxide, the products of the condensation of aliphatic alcohols with ethylene oxide, products of the condensation of ethylene oxide with a hydrophobic base formed by the condensation of propylene oxide with propylene glycol, and condensation products of ethylene oxide with the product resulting from the reaction of propylene oxide with ethylene diamine. Another variety of nonionic surfactants are non-polar nonionic surfactants, typified by amine oxide surfactants. Preferred nonionic surfactants include ceteareth-20, steareth-20 and ceteth-2. You can also add salts and regulatory solutions in order to modify the rheology of the product. For example, salts such as potassium chloride, ammonium chloride and sodium chloride may be added in amounts of about 0.001 to about 1%. Regulatory solutions such as citrate or phosphate buffer solutions can also be added. The formulations of the present as finally formulated, preferably have a pH of from about 3 to about 10, preferably from about 3 to about 7. Additional conditioning components can also be incorporated into the formulations. For example, proteins can be added in amounts of about 0.1 to about 10%. Cationic proteins can serve as surfactant carrier materials. Thickening agents are preferred optional components. Such thickeners include nonionic thickening agents that are incorporated in amounts of about 0.1 to about 8%. Such agents are polymers that exhibit viscosities that exceed about 20,000 cp at low cut (approximately 10"2 sec" 1). Some examples are polyoxyethylene, guara gum, methylcellulose, methylhydroxypropylcellulose, polypropylcellulose, polypropylhydroxyethylcellulose, hydroxyethylcellulose, starches and starch derivatives and mixtures thereof. Nonionic thickening agents are described in U.S. Patent No. 4,387,090 (Bolich et al., Issued June 7, 1983). The thickening agents are used to give the formulation a viscosity of about 10.625 to about 14.375 cp (measured with a Wells-Brookfield viscometer, model RVT DV-CP-2, model DV-11, model
Cone CP-52, using H ml at 1 r.p.m., at 26.7 ° C for 1 minute). The hair conditioner formulations of the present invention are generally used on the hair after all the shampoo has been removed by rinsing with water. The present invention also provides a method for treating human hair to kill and facilitate the removal of lice and lice eggs, comprising the steps of: (a) applying from about 10 to about 30 grams of a formulation of the present invention , to damp hair; (b) rubbing the formulation throughout the scalp; (c) leaving the formulation in the hair and scalp for approximately 6 to 10 minutes; and (d) removing the hair formulation by rinsing with water. Lotions against lice that comprise a spinosyn or a physiologically acceptable salt or derivative thereof and a lotion vehicle are another aspect of the present invention. These lotions can be applied directly to hair in liquid form or in the form of dew. They are formulated to be applied to hair
»< »* A - *? J < ma »j. »-,. c • t ^ rl? Ja > llíutt? ß ^? ^! ?? "Jíi ~ ^ tai) tur« tr. ·. I. Yi¡-yS ^? Í ^ mt¿í? T?., ^. ». > Y ¿, '-? Í ^ ? ...... «K« »" ut- ^ «*«. »Nra» *? & .2, * ..
for a period of time and not immediately removed by rinsing with water. When used in a lotion formulation, the spinosyn component is generally present in an amount of from about 0.1 to about 30%, preferably from about 1 to about 10%. In addition to the spinosyn component, the lotion formulations comprise a liquid carrier such as alcohol, water or a mixture thereof, to assist
to the distribution of the spinosyn component in the hair. Suitable alcohols are monohydric alcohols such as methanol, ethanol, isopropanol or mixtures thereof. As the alcohols can have a deteriorating effect on the stability of the
formulations, water alone is preferred as a vehicle. The vehicle is added in an amount sufficient for (c.b.p.) that the formulation reaches 100%. The lotion formulations may include optional components to provide benefits to the hair in addition to the activity against lice. Optional components include: preservatives and antimicrobials, such as DMDM hydantoin and tetrasodium AEDT; agents for pH balancing such as sodium citrate and citric acid; emulsifiers such as 5 PEG-60, castor oil; and thickeners and modifiers
&UMÚL k * - & *. ? .A-, viscosity such as polyvinylpyrrolidone. When included, such components are generally used individually in amounts of about 0.01 to about 10%. It is possible to include conditioning agents to facilitate the removal of dead lice and eggs from the hair and to provide a good combing both wet and dry. The same types of conditioning agents described in the supra conditioning formulations can be used in the lotions; these include quaternary ammonium salts, fatty amines and mixtures thereof. The conditioning agents are used in amounts of from about 0.1 to about 1%, preferably from about 0.4 to about 0.6%. The preferred conditioning agents are the quaternary ammonium salts. Preferred quaternary ammonium salts include dialkyldimethylammonium chloride, wherein the alkyl groups have from 12 to 22 carbon atoms. These alkyl groups can be derived from long chain fatty acids, such as hydrogenated tallow fatty acid. The tallow fatty acid gives rise to quaternary compounds in which Ri and R2 predominantly have 16 to 18 carbon atoms. Examples of quaternary ammonium salts useful in lotion formulations include di (tallow) chloride
m.sub.2 * hydrogenated) -dimethylammonium, dicetyldimethylammonium chloride, tricetylmethylammonium chloride, cetyltrimethylammonium chloride, stearyldimethylbenzylammonium chloride and mixtures thereof. The most preferred 5 is dicetyl dimethyl ammonium chloride. It is also possible to add synergistic agents of alcohol to the lotion formulations to increase their activity against lice. The alcohols used in the lotion formulations are selected from the group
consists of phenylalkanols of 2 to 6 carbon atoms, phenyldiols of 2 to 6 carbon atoms, alkylene diols of 2 to 8 carbon atoms and mixtures thereof. These synergistic agents can be included in amounts of about 0.25 to about 10%, wherein the
The amount of phenylalkanols, phenyldiols and mixtures thereof does not exceed 5% of the formulation. Preferably, the amount is from about 0.5 to about 5% of the formulation, more preferably from about 2 to about 4%. A preferred synergistic agent is
Hexylene glycol. The lotion formulations are applied directly to the hair. The amount of lotion used generally ranges from about 10 to about 50 ml. The lotion is rubbed on the hair and left on the
for about 10 minutes, preferably,
for approximately 30 minutes. Then the hair is cleaned, usually with a shampoo, before rinsing with water. The following examples illustrate the formulations of the present invention. EXAMPLE 1 A lotion formulation was prepared as follows:
Spinosyn is added to a tank containing a mixture of PEG-60 castor oil, hexylene glycol, propylene glycol and dicetyl dimethyl ammonium chloride, at a temperature between 35 and 38 ° C. In a second tank, it
to mix the polyvinylpyrrolidone, DMDM hydantoin, tetrasodium AEDT and citric acid and the mixture is brought to a temperature between 35 and 38 ° C. The contents of the first tank are added to the second tank and mixed until the mixture is uniform. The mixture is cooled to approximately 27 ° C and distributed in storage tanks. EXAMPLE 2 A lotion formulation was prepared using the procedure described in Example 1, but with the following formula:
EXAMPLE 3 A lotion formulation was prepared by the procedure described in Example 1, but with the following formula:
To control an infestation by lice, the lotion formulations of Examples 1 to 3 are applied to the hair and left for at least an hour before being removed by shampooing or shampooing.
rinse with water.
EXAMPLE 4 A shampoo formulation was prepared in the following manner:
The ammonium lauryl sulfate is added to a tank and heated to a temperature between 66 and about 69 ° C. While maintaining this temperature, an aqueous solution of monosodium phosphate is added and then an aqueous solution of disodium phosphate. When reaching 69 ° C,
Ammonium xylene sulfonate is added to the mixture and heated to a temperature of about 74 to
about 11 ° C; the coconut monoethanolamide is added, mixed until well dispersed, the ethylene glycol distearate added and approximately 4.5% water. The mixture is continued until it is homogeneous and cooled to approximately 41 ° C. The mixture is pumped into a second tank and ammonium laurethulfate, DMDM hydantoin and an aqueous solution of citric acid are added. The spinosyn is added to the second tank and an amount of water c.b.p. 100% It is mixed well, cooled to a temperature of about 27 ° C and the mixture is pumped into storage tanks. EXAMPLE 5 A shampoo formulation was prepared in the following manner:
xThe silicone rubber is obtained from The General Electric Co. under the name Goma SE-30 or SE-76. Approximately 0.5% of ammonium laureth sulfate and dimethicone are added to a vessel and mixed for approximately 30 minutes. Approximately 2% ammonium laurethulfate is added to a processing tank and heated to a temperature of 68 to 71 ° C. Approximately 0.12% stearyl alcohol, approximately 0.06% cetyl alcohol and the contents of the first container are added to the processing tank. Mix until uniform, keeping the mixture at a temperature between 68 and 71 ° C. To a second processing tank, ammonium lauryl sulfate is added and heated to approximately 71 ° C. Maintaining this
. * * & a & ^ and temperature, 0.05% ammonium chloride, approximately 18% water, ammonium xylene sulfonate and the rest of stearyl alcohol and cetyl alcohol are added. To the second tank are added coconut monoethanolamide, tricetylmethylammonium chloride, ethylene glycol distearate, approximately half of the DMDM hydantoin and the contents of the first tank, maintaining the temperature at approximately 77 ° C. Mix until the mixture is homogeneous and then cool to
about 41 ° C. The mixture is pumped to a third tank and the rest of the ammonium laureth sulfate, DMDM hydantoin and sodium chloride are added. Spinosyn is added to the mixture and a quantity c.b.p. 100% water Mix well, cool to a temperature of
approximately 27 ° and the mixture is pumped to storage tanks. EXAMPLE 6 A shampoo formulation was prepared in the following manner:
Approximately 6.5% of the water and ammonium laureth sulfate are added to a mixing tank and the mixture is heated to a temperature of about 35 ° C. Maintaining this temperature, the following components are added individually and in sequence, mixing each component so that it is incorporated well into the batch: ammonium lauryl sulfate, ammonium xylene sulfonate, monosodium phosphate, disodium phosphate, DMDM hydantoin,
sodium, a solution of citric acid and water, a solution of coconut diethanolamine and isostearylethylammonium ethosulfate. Spinosyn is added to the mixture and a quantity of water c.b.p. 100% Mix well, cool to approximately 27 ° C and mix pumped
to storage tanks.
EXAMPLE 7 A conditioner formulation was prepared in accordance with the present invention, as follows:
xThe silicone rubber is available from The General Electric Co. under the name Goma SE-30 or SE-76. All components are combined, except DMDM hydantoin, citric acid, silicone rubber, cyclomethicone
* .- -ß-á A ta & & - & amp &ms & * fcik¿ aft •: -.? ¿s¿- -.
and espmosina, in a processing tank and the mixture is heated to approximately 88 ° C. After the solution is well mixed, it is cooled to approximately 48 ° C. In a separate tank, the silicone rubber and the cyclomethicone are mixed, heating and stirring to form a gum solution. Spinosyn is added to this mixture. The gum solution and all the remaining components are added and water c.b.p. Mix well, cool to approximately 27 ° C and mix pumped to storage tanks. EXAMPLE 8 A conditioning formulation was prepared by the procedure described in Example 7, but using the following formula:
xThe silicone rubber is available from The General Electric Co. under the name Goma SE-30 or SE-76. This lice conditioner product is prepared in a manner similar to that described in Example 7. EXAMPLE 9 Efficacy of Shampoo Formulations Shampoo formulations containing various concentrations of spinosad were used in this study. The formulations were prepared by wet grinding for 30 minutes, with sufficient technical grade spinosad in a commercially available shampoo (Johnson 's® Baby Shampoo, Honey and Vitamin E Moisturizing Formula, Johnson &Johnson Consumer Products, Inc. ) to form a 10% spinosad / shampoo concentrate. This mixture was diluted with additional shampoo to prepare the following concentrations of spinosad: 10% (used
as originally prepared), 1%, 0.1% and 0.01% spinosad / shampoo (w / w). The four concentrations of spinosad in shampoo and a control of tap water were tested against adult human lice (Pediculus humanus humanus) in accordance with a standard test, ASTM Standard E 938-83 (Reapproved 1988), this is available in the North American Society for Test and Materials, 100 Barr Harbor Drive, West Conshohocken, Pennsylvania, USA [http://www.astm.org/] In this test, 25 lice were immersed in each of the four shampoo concentrations for 10 minutes, then washed with water for 1 minute and rinsed with water for another minute. In the control group, 25 adult lice (Pediculus humanus humanus) were immersed in running water for 10 minutes, then washed with water for 1 minute and rinsed with water for another minute. A total of 5 trials were performed. After one hour, the lice were examined to determine the number of knocked down. The number of "knocked down" was measured as the rapid immobilization (within a period of one minute) of the activity of the insect that causes from a moribund state to death). After 24 hours, the lice were examined again to determine the number of deaths. The results of this study are summarized in Table 1. TABLE 1 Comparison of Pediculicidal Effects of Espinosad in Shampoos at Various Concentrations
The study showed that shampoo formulations containing 1 and 10% spinosad were highly effective as pediculicides, providing a mortality
+24 hours of 100%. The 10% concentration produced the most rapid knockdown effect (96.6% in +1 hour) and even the 1% concentration produced a knockdown rate of 48%. The 0.1% spinosad / shampoo formulation was also an effective pediculicide,
providing almost 100% mortality after 24 hours.
A6á? »Mie ¿&Mj It is noted that in relation to this date, the best method known by the applicant to carry out the aforementioned invention, is the conventional one for the manufacture of the objects to which it refers.
Claims (15)
- CLAIMS Having described the invention as an antecedent, the content of the following claims is claimed as property: 1. A formulation for controlling the infestation by lice in a human being, characterized in that it comprises as an active ingredient a spinosyn or a physiologically acceptable salt or derivative thereof. the same, associated with a physiologically acceptable vehicle.
- 2. A formulation according to claim 1, characterized in that it is a hair care formulation.
- 3. A formulation according to any of claims 1 or 2, characterized in that it is a shampoo.
- 4. A formulation according to any of claims 1, 2 or 3, characterized in that it additionally comprises a surfactant.
- 5. A formulation according to any of claims 3 or 4, characterized in that it comprises: (a) from about 0.1 to about 2.556 of a spinosyn, or a physiologically acceptable salt or derivative thereof; (b) from about 5 to about 30% of a synthetic surfactant; (c) from about 1 to about 7% of an amide; and (d) water.
- 6. A formulation according to any of claims 1 to 5, characterized in that it further comprises from about 1 to about 10% of a non-volatile silicone material.
- 7. A formulation according to any of claims 1 to 6, characterized in that it additionally comprises from about 0.5 to about 5% of a suspending agent.
- 8. The use of a spinosyn or a physiologically acceptable derivative or salt thereof, or a formulation containing any of these entities, for the manufacture of a medicament for controlling lice in a human being.
- 9. The use according to claim 8, characterized in that the louse is Pediculus humanus capi tis or Pediculus humanus humanus.
- 10. The use according to claim 10, characterized in that the louse is Pthirus pubis.
- 11. A method for controlling a lice infestation in a human being, characterized in that it comprises the topical administration of a formulation according to any of claims 1 to 4, to the human.
- 12. The method according to claim 11, characterized in that the louse causing the infestation is Pediculus humanus capi tis.
- 13. The method according to claim 11, characterized in that the louse causing the infestation is Pediculus humanus humanus.
- The method according to claim 11, characterized in that the louse causing the infestation is Pthirus pubis.
- 15. A method for treating human hair to kill and facilitate the removal of lice and their eggs, characterized in that it comprises the steps of: (a) applying from about 10 to about 30 g of a formulation comprising a spinosyn or a derivative or physiologically acceptable salt thereof, and a physiologically acceptable carrier, to wet hair; (b) rub the formulation on the entire hair and scalp; (c) leaving the formulation in the hair and scalp for approximately 6 to 10 minutes; and (d) removing the hair formulation by rinsing with water.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60/091,658 | 1998-07-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA00012905A true MXPA00012905A (en) | 2001-09-07 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU750046B2 (en) | Formulations for controlling human lice | |
| US5292504A (en) | Anti-lice treatment compositions | |
| US5288483A (en) | Anti-lice treatment compositions | |
| US20110118196A1 (en) | Anti-phthiraptera treatment compositions | |
| CN101912381A (en) | Methods and compositions for treating ectoparasite infestation | |
| EP0593459B1 (en) | Anti-lice treatment compositions | |
| MXPA00012905A (en) | Formulations for controlling human lice | |
| KR19980074159A (en) | Anti-dandruff hair cosmetic composition | |
| KR19980074158A (en) | Anti-dandruff hair treatment composition |